top of page

CHO-K1/Human GHRH Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0102A

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


The growth hormone-releasing hormone receptor (GHRHR) is a G protein-coupled receptor that specifically binds to growth hormone-releasing hormone (GHRH) secreted by the hypothalamus. It is primarily located on growth hormone-secreting cells (somatotrophs) in the anterior pituitary, with additional expression in the hypothalamus, pancreas, immune cells, and various peripheral tissues and tumors. Its core function is to potently stimulate the synthesis and pulsatile secretion of growth hormone (GH) by activating the Gαs-cAMP-PKA signaling pathway, thereby governing body linear growth, metabolism, and cellular repair. As a central component of the hypothalamic-pituitary growth axis, its overactivity is linked to acromegaly, while its deficiency leads to growth hormone deficiency, making it a critical target for the diagnosis and treatment of related endocrine disorders (e.g., GHRH analogs).

 

Screeningbio’s CHO-K1/Human GHRH cell line overexpress GHRHR receptor and is designed to detect increases in intracellular cAMP levels in response to agonist stimulation of the receptor. Cisbio HTRF cAMP kit can be used to detect the signal.

Product Specifications

Target Type

GPCR

Species

Human

HGNC Symbol

GHRHR

Accession Number

NM_000823

Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data


CHO-K1/Human GHRH Agonist Assay. CHO-K1/Human GHRH cells were treated with the reference agonist. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
CHO-K1/Human GHRH Agonist Assay. CHO-K1/Human GHRH cells were treated with the reference agonist. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.


Target Background


The growth hormone-releasing hormone receptor (GHRHR) is a G protein-coupled receptor primarily found on somatotrophs in the pituitary gland. Its key function is to bind GHRH, activating the cAMP pathway to stimulate growth hormone (GH) synthesis and pulsatile secretion, thereby regulating body growth and metabolism.


Dysregulation of GHRHR is directly linked to endocrine disorders such as acromegaly (overactivity) and growth hormone deficiency (underactivity), making it a critical therapeutic target.

 



Product Documentation



bottom of page